Capricor Therapeutics
CAPR
CAPR
31 hedge funds and large institutions have $18.1M invested in Capricor Therapeutics in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
12% less capital invested
Capital invested by funds: $20.5M → $18.1M (-$2.4M)
70% less call options, than puts
Call options by funds: $683K | Put options by funds: $2.25M
Holders
31
Holding in Top 10
–
Calls
$683K
Puts
$2.25M
Top Buyers
| 1 | +$503K | |
| 2 | +$373K | |
| 3 | +$368K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$170K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$120K |
Top Sellers
| 1 | -$4.27M | |
| 2 | -$1.26M | |
| 3 | -$216K | |
| 4 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$144K |
| 5 |
MHS
M Holdings Securities
Portland,
Oregon
|
-$94K |